1 Stop Chicken Health Shop – FDA Warning Letter, Aug 27, 2024

On July 29, 2024, the FDA issued a Warning Letter to Marissa Weaver concerning the marketing of unapproved new animal drugs via the website https://www.1stopchickenhealthshop.com/ and a Facebook page. From January to March 2024, the FDA reviewed these platforms, identifying products such as Coccibuster Toltrazuril, Endocox Powder, Toltrazuril 2.5 10mL Syringe, Tony’s Treasure Tablets, Enrofloxacin 30 mg tablets, Enrofloxacin 10mg Tabs, and Enrofloxacin 10% (Baytril) Liquid 15 mL Bottles.

The FDA determined these products are drugs under section 201(g)(1)(B) of the FD&C Act due to claims indicating their use for diagnosis, cure, mitigation, treatment, or prevention of disease in animals, or to affect animal body structure/function. They are also misbranded under section 502(o) because they are not drug listed with the FDA. Introducing these unapproved and misbranded drugs into interstate commerce violates section 301(a) of the FD&C Act.

Furthermore, these products are considered new animal drugs under section 201(v) as they are not generally recognized as safe and effective. Without an approved new animal drug application, conditionally approved application, or index listing (